A medical facility in California was struck by a Candida auris outbreak (a type of drug-resistant fungus), impacting their ICU, 40 patient rooms, and other wings of the facility. The facility did not have the equipment or training to address this highly communicable fungus.
ATI provided CDC-satisfactory disinfection that stopped the life-threatening fungus. Working with key facility staff, ATI successfully implemented a Disinfection Management Plan for impacted areas, including multiple cleanings, aerosolized hydrogen peroxide dry-fogging, shutting off the HVAC system to impacted rooms and monitoring airflow for cross contamination.

The Situation

On top of the escalating COVID-19 pandemic, a Southern California medical center tackled an outbreak of Candida auris (C. auris) in its Intensive Care Unit (ICU), affecting 40 patient rooms and other wings of the facility.

C. auris is an emerging multidrug-resistant yeast (a type of fungus). It can cause severe infections and spreads quickly between hospitalized patients and nursing home residents. Patients can carry C. auris somewhere on their body, even if it is not making them sick. This is called colonization. When people in hospitals and nursing homes are colonized, C. auris can spread from their bodies and can transfer on other people or nearby objects, allowing the fungus to spread to others around them.

The medical center did not have the equipment and/or training to perform the highly specialized work. Through an Emergency Response Agreement with the facility’s owner, ATI Restoration provided enhanced touch-less disinfection using aHP (aerosolized hydrogen peroxide) dry-fogging application.

The Solution

In collaboration with the Infection Control Nurse, Environmental Services (EVS) and Facility Engineering staff, ATI developed a site-specific Disinfection Management Plan (DMP) for each room as follows.

1. Prior to dry-fogging with aerosolized hydrogen peroxide:

i. EVS staff, wearing full personal protective equipment, performed terminal cleaning followed by a second deep clean, focusing on high touch surfaces and high-use objects. EVS staff removed the mattress from patient beds and tilted them on their side to be disinfected.

ii. Facility Engineering staff shutdown the HVAC system servicing each patient room and balanced the airflow in adjacent occupied patient rooms.

iii. ATI installed critical barriers to isolate and seal each patient room. The supply diffusers and return grilles were sealed with 6-mil poly and vinyl tape to prevent the aerosolized hydrogen peroxide from migrating throughout the ductwork. The smoke detectors were covered.

iv. ATI placed 4 Chemical Indicator strips (Cls) throughout the patient room to assure consistent delivery of the disinfectant mist dispensed by the Halofogger.

v. ATI positioned the Halofogger in the corner of the room approximately one foot away from the wall, ensuring the dispensing airflow pathway was unobstructed during the treatment process. ATI turned on the Halofogger and exited the patient room.

2. Application and Disinfection Period:

i. ATI maintained a written log for each patient room. The log contained the run time, number of readings taken and level of concentrations found in each location.

ii. ATI monitored the perimeter for any leaks and documented that DMHP was not present above the 0.2 ppm-level.

iii. ATI re-entered the treated room once DMHP levels were determined to be at or below one ppm, and removed all sealing materials, including any covered fire alarms, and the Halo Fogger from the treated room.

iv. The Facility Engineer turned on the HVAC system. All placards and critical barriers were removed by ATI and the patient room was released back to the ICU Department for normal operation.

Following this process, a representative from the CDC conducted an investigation to review the procedures and methods implemented by the Hospital and ATI and found proccesses implemented to be satisfactory in combating the spread of this life-threatening organism.

Download Now
Live Chat